Evidence map›Paper›PMID 23764849›Full record

ArticleCell death & disease2013

miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development.

W Wei, H-B He, W-Y Zhang, H-X Zhang, J-B Bai, H-Z Liu, J-H Cao, K-C Chang, X-Y Li, S-H Zhao

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 182 citations in OpenAlex.

  1. Review
  2. CircRNACells · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Release of miR-29 Target Laminin C2 Improves Skin Repair.The American journal of pathology · 2024
    Article
  8. Comparative Genomics Identifies the Evolutionarily Conserved GeneInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. CircEpigenetics · 2022
    Article
  14. Bioinformatics analysis identification ofExperimental and therapeutic medicine · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

W WeiKey Laboratory of Animal Genetics, Breeding and Reproduction of Ministry of Education, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, PRC.
H-B He
W-Y Zhang
H-X Zhang
J-B Bai
H-Z Liu
J-H Cao
K-C Chang
X-Y Li
S-H Zhao
Huazhong Agricultural University · CNUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are a type of endogenous noncoding small RNAs involved in the regulation of multiple biological processes. Recently, miR-29 was found to participate in myogenesis. However, the underlying mechanisms by which miR-29 promotes myogenesis have not been identified. We found here that miR-29 was significantly upregulated with age in postnatal mouse skeletal muscle and during muscle differentiation. Overexpression of miR-29 inhibited mouse C2C12 myoblast proliferation and promoted myotube formation. miR-29 specifically targeted Akt3, a member of the serine/threonine protein kinase family responsive to growth factor cell signaling, to result in its post-transcriptional downregulation. Furthermore, knockdown of Akt3 by siRNA significantly inhibited the proliferation of C2C12 cells, and conversely, overexpression of Akt3 suppressed their differentiation. Collectively and given the inverse endogenous expression pattern of rising miR-29 levels and decreasing Akt3 protein levels with age in mouse skeletal muscle, we propose a novel mechanism in which miR-29 modulates growth and promotes differentiation of skeletal muscle through the post-transcriptional downregulation of Akt3.

Indexed as

Cell ProliferationMuscle Development3' Untranslated RegionsAnimalsBase SequenceBinding SitesCell CycleCell DifferentiationCell LineConserved SequenceEnzyme RepressionGene ExpressionMaleMiceMice, Inbred BALB CMicroRNAs3' Untranslated RegionsAkt3 protein, mouseMicroRNAsMIRN29 microRNA, mouseProto-Oncogene Proteins c-akt

Identifiers

PMID23764849
PMCPMC3698551
OpenAlexW2018105329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.